Association of oncological response between the first-line chemotherapy and subsequent immune checkpoint inhibitors therapy in patients with unresectable or metastatic urothelial carcinoma

被引：1
|
作者：
Ozaki, Kai [1 ]
Hatakeyama, Shingo [2 ]
Hamaya, Tomoko [1 ]
Okita, Kazutaka [1 ]
Hashimoto, Yasuhiro [1 ]
Ohyama, Chikara [1 ,2 ]
机构：
[1] Hirosaki Univ, Grad Sch Med, Dept Urol, Hirosaki, Aomori, Japan
[2] Hirosaki Univ, Grad Sch Med, Dept Adv Blood Purificat Therapy, Hirosaki, Aomori, Japan
来源：
INTERNATIONAL JOURNAL OF UROLOGY | 2022年 / 29卷 / 04期
基金：
日本学术振兴会;
关键词：
D O I：
10.1111/iju.14778
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：362 / 364
页数：3
相关论文
共 50 条
  • [21] Immunological Correlates of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma
    Tzeng, Alice
    Diaz-Montero, C. Marcela
    Rayman, Patricia A.
    Kim, Jin S.
    Pavicic, Paul G., Jr.
    Finke, James H.
    Barata, Pedro C.
    Lamenza, Marcelo
    Devonshire, Sarah
    Schach, Kim
    Emamekhoo, Hamid
    Ernstoff, Marc S.
    Hoimes, Christopher J.
    Rini, Brian I.
    Garcia, Jorge A.
    Gilligan, Timothy D.
    Ornstein, Moshe C.
    Grivas, Petros
    TARGETED ONCOLOGY, 2018, 13 (05) : 599 - 609
  • [22] Treatment Options for Metastatic Urothelial Carcinoma After First-Line Chemotherapy
    Tassinari, Elisa
    Mollica, Veronica
    Nuvola, Giacomo
    Marchetti, Andrea
    Rosellini, Matteo
    Massari, Francesco
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 1945 - 1960
  • [23] First-line immune checkpoint inhibitors in advanced or metastatic renal cell carcinoma with sarcomatoid features
    Fontes-Sousa, Mario
    Calvo, Emiliano
    CANCER TREATMENT REVIEWS, 2022, 105
  • [24] Effectiveness of First-line Immune Checkpoint Blockade Versus Carboplatin-based Chemotherapy for Metastatic Urothelial Cancer
    Feld, Emily
    Harton, Joanna
    Meropol, Neal J.
    Adamson, Blythe J. S.
    Cohen, Aaron
    Parikh, Ravi B.
    Galsky, Matthew D.
    Narayan, Vivek
    Christodouleas, John
    Vaughn, David J.
    Hubbard, Rebecca A.
    Mamtani, Ronac
    EUROPEAN UROLOGY, 2019, 76 (04) : 524 - 532
  • [25] Beyond First-Line Immune Checkpoint Inhibitor Therapy in Patients With Hepatocellular Carcinoma
    Sharma, Rohini
    Aval, Leila Motedayen
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [26] First Report of Oncological Outcome and Prognostic Analysis in a First-Line Setting of Short Hydration Gemcitabine and Cisplatin Chemotherapy for Patients with Metastatic Urothelial Carcinoma
    Naiki, Taku
    Nagai, Takashi
    Sugiyama, Yosuke
    Etani, Toshiki
    Nozaki, Satoshi
    Iida, Keitaro
    Noda, Yusuke
    Shimizu, Nobuhiko
    Isobe, Teruki
    Matsumoto, Daisuke
    Kubota, Hiroki
    Hamamoto, Shuzo
    Ando, Ryosuke
    Kawai, Noriyasu
    Yasui, Takahiro
    ONCOLOGY, 2021, 99 (10) : 622 - 631
  • [27] Response to salvage chemotherapy after progression on immune checkpoint inhibitors in patients with advanced urothelial carcinoma
    Beom, Seung-Hoon
    Rha, Sun Young
    Ahn, Joong Bae
    Shin, Sang Joon
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [28] Efficacy of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma
    Birsen, Gary
    Gounant, Valerie
    Girard, Nicolas
    Cadranel, Jacques
    Monnet, Isabelle
    Raynaud-Donzel, Christine
    Fabre, Elizabeth
    Leprieur, Etienne Giroux
    Leroy, Karen
    Damotte, Diane
    Alifano, Marco
    Arrondeau, Jennifer
    Creme, Isabelle
    Chapron, Jeanne
    Wislez, Marie
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (09)
  • [29] EFFECTS OF FIRST-LINE IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA NOT MEETING TRIAL ELIGIBILITY CRITERIA
    Nemoto, Yuki
    Ishihara, Hiroki
    Nakamura, Kazutaka
    Tachibana, Hidekazu
    Fukuda, Hironori
    Yoshida, Kazuhiko
    Kobayashi, Hirohito
    Iizuka, Junpei
    Shimmura, Hiroaki
    Hashimoto, Yasunobu
    Tanabe, Kazunari
    Kondo, Tsunenori
    Takagi, Toshio
    JOURNAL OF UROLOGY, 2022, 207 (05): : E173 - E173
  • [30] Trend in overall survival from the start of first-line chemotherapy in patients with metastatic urothelial carcinoma
    Yamamoto, Shoma
    Kato, Minoru
    Matsue, Taisuke
    Yukimatsu, Nao
    Takeyama, Yuji
    Otoshi, Taiyo
    Yamasaki, Takeshi
    Kuratsukuri, Katsuyuki
    Uchida, Junji
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (02) : 221 - 224
12345